论文部分内容阅读
目的:分析甲状腺弥漫性病变合并甲状腺癌的超声诊断价值。方法:选择2016年1月至2017年1月本院手术病理确诊的40例甲状腺弥漫性病变合并甲状腺癌患者作为研究对象,在此之前,所有患者均经超声诊断检查,以手术病理诊断结果作为金标准,对比分析超声诊断检查在甲状腺弥漫性病变合并甲状腺癌中的诊断准确率。结果:40例甲状腺弥漫性病变合并甲状腺癌患者经手术病理确诊,其中包括12例良性病灶、28例恶性病灶。40例患者经超声诊断检查出10例良性病灶、26例恶性病灶,诊断准确率为90%(36/40),漏诊4例(10%)。其与手术病理诊断相比,差异不明显,P>0.05。结论:针对甲状腺弥漫性病变合并甲状腺癌患者,可通过超声诊断检查,为临床诊断及治疗提供有利的参考依据,可作为诊断甲状腺弥漫性病变合并甲状腺癌的常规检查。
Objective: To analyze the diagnostic value of diffuse thyroid disease with thyroid carcinoma by ultrasonography. Methods: From January 2016 to January 2017, 40 patients with thyroid diffuse lesions diagnosed as thyroid cancer in our hospital were enrolled in this study. All patients were examined by ultrasonography before operation. The results of pathological diagnosis as Gold standard, comparative analysis of diagnostic ultrasound in thyroid diffuse lesions with thyroid cancer diagnostic accuracy. Results: Forty thyroid diffuse lesions with thyroid cancer were confirmed by surgery and pathology, including 12 benign lesions and 28 malignant lesions. Forty patients underwent ultrasonography to diagnose 10 cases of benign lesions and 26 cases of malignant lesions. The diagnostic accuracy was 90% (36/40) and 4 cases (10%) were missed. Compared with the surgical pathological diagnosis, the difference was not significant (P> 0.05). Conclusion: The thyroid diffuse lesions in patients with thyroid cancer can be diagnosed by ultrasound and provide a good reference for clinical diagnosis and treatment, which can be used as a routine diagnosis of thyroid diffuse lesions with thyroid cancer.